Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.
The move signals a major expansion milestone for the Swiss laboratory automation company
Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery
The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”
The approval was granted by Agenzia Italiana del Farmaco
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
